Furthermore, in gastric cancer, E2F1 was a potential downstream target of CHPF, and knockdown of E2F1 reduced the CHPF-induced promotion of gastric cancer (Lin et al., 2021a). The gene discussed is E2F1; the disease is gastric cancer.